Suppr超能文献

蛋白酶体抑制剂的抗锥虫活性。

Antitrypanosomal activities of proteasome inhibitors.

作者信息

Nkemngu Njinkeng Joseph, Rosenkranz Vera, Wink Michael, Steverding Dietmar

机构信息

Abteilung Parasitologie, Hygiene-Institut. Institut für Pharmazeutische Biologie, Ruprecht-Karls-Universität, Heidelberg, Germany.

出版信息

Antimicrob Agents Chemother. 2002 Jun;46(6):2038-40. doi: 10.1128/AAC.46.6.2038-2040.2002.

Abstract

Seven peptidyl proteasome inhibitors were tested for in vitro activity against Trypanosoma brucei bloodstream forms. Two compounds showed activity in the low nanomolar range. In general, trypanosomes were more susceptible to the compounds than were human HL-60 cells. The data support the potential of proteasome inhibitors for rational antitrypanosomal drug development.

摘要

测试了七种肽基蛋白酶体抑制剂对布氏锥虫血流形式的体外活性。两种化合物在低纳摩尔范围内显示出活性。总体而言,锥虫比人类HL-60细胞对这些化合物更敏感。这些数据支持蛋白酶体抑制剂在合理开发抗锥虫药物方面的潜力。

相似文献

1
Antitrypanosomal activities of proteasome inhibitors.
Antimicrob Agents Chemother. 2002 Jun;46(6):2038-40. doi: 10.1128/AAC.46.6.2038-2040.2002.
2
Trypanocidal activity of β-lactone-γ-lactam proteasome inhibitors.
Planta Med. 2012 Jan;78(2):131-4. doi: 10.1055/s-0031-1280315. Epub 2011 Oct 27.
3
Trypanocidal activity of peptidyl vinyl ester derivatives selective for inhibition of mammalian proteasome trypsin-like activity.
Exp Parasitol. 2011 Aug;128(4):444-7. doi: 10.1016/j.exppara.2011.03.015. Epub 2011 Mar 31.
4
Trypanocidal activities of trileucine methyl vinyl sulfone proteasome inhibitors.
Parasitol Res. 2005 Jan;95(1):73-6. doi: 10.1007/s00436-004-1253-y. Epub 2004 Dec 1.
5
Screening of acyl hydrazide proteinase inhibitors for antiparasitic activity against Trypanosoma brucei.
Int J Antimicrob Agents. 2002 Mar;19(3):227-31. doi: 10.1016/s0924-8579(01)00488-5.
7
Improved trypanocidal activities of cathepsin L inhibitors.
Int J Antimicrob Agents. 2003 Aug;22(2):155-9. doi: 10.1016/s0924-8579(03)00096-7.
8
Trypanosoma brucei: β2-selective proteasome inhibitors do not block the proteasomal trypsin-like activity but are trypanocidal.
Mol Biochem Parasitol. 2019 Jan;227:1-4. doi: 10.1016/j.molbiopara.2018.11.002. Epub 2018 Nov 13.
9
Evaluation of the anti-trypanosomal activity of tyropeptin A.
Planta Med. 2006 Jun;72(8):761-3. doi: 10.1055/s-2006-931600. Epub 2006 May 29.

引用本文的文献

1
Carmaphycin B-Based Proteasome Inhibitors to Treat Human African Trypanosomiasis: Structure-Activity Relationship and Efficacy.
ACS Infect Dis. 2024 Dec 13;10(12):4182-4193. doi: 10.1021/acsinfecdis.4c00441. Epub 2024 Nov 26.
2
Identification of a Proteasome-Targeting Arylsulfonamide with Potential for the Treatment of Chagas' Disease.
Antimicrob Agents Chemother. 2022 Jan 18;66(1):e0153521. doi: 10.1128/AAC.01535-21. Epub 2021 Oct 4.
3
Cell communication and protein degradation: All in one parasitic package.
J Extracell Vesicles. 2021 Jul;10(9):e12116. doi: 10.1002/jev2.12116. Epub 2021 Jul 5.
4
Ubiquitination and the Proteasome as Drug Targets in Trypanosomatid Diseases.
Front Chem. 2021 Jan 28;8:630888. doi: 10.3389/fchem.2020.630888. eCollection 2020.
6
Effects of proteasome inhibitor MG-132 on the parasite Schistosoma mansoni.
PLoS One. 2017 Sep 12;12(9):e0184192. doi: 10.1371/journal.pone.0184192. eCollection 2017.
7
The Dialogue of the Host-Parasite Relationship: Leishmania spp. and Trypanosoma cruzi Infection.
Biomed Res Int. 2015;2015:324915. doi: 10.1155/2015/324915. Epub 2015 May 18.
8
Autophagy in trypanosomatids.
Cells. 2012 Jul 27;1(3):346-71. doi: 10.3390/cells1030346.
9
Antiparasitic chemotherapy: from genomes to mechanisms.
Annu Rev Pharmacol Toxicol. 2014;54:71-94. doi: 10.1146/annurev-pharmtox-011613-135915. Epub 2013 Sep 11.

本文引用的文献

2
Ubiquitin proteasome pathway: implications and advances in cancer therapy.
Surg Oncol. 2001 Jul-Aug;10(1-2):43-52. doi: 10.1016/s0960-7404(01)00018-4.
3
In vitro effect of alkaloids on bloodstream forms of Trypanosoma brucei and T. congolense.
Planta Med. 2001 Oct;67(7):623-7. doi: 10.1055/s-2001-17351.
4
Proteasome inhibitors: from research tools to drug candidates.
Chem Biol. 2001 Aug;8(8):739-58. doi: 10.1016/s1074-5521(01)00056-4.
5
Proteasome inhibitors: from in vitro uses to clinical trials.
J Pept Sci. 2000 Sep;6(9):478-88. doi: 10.1002/1099-1387(200009)6:9<478::AID-PSC285>3.0.CO;2-F.
6
Proteasome inhibitors as anti-cancer agents.
Anticancer Drugs. 2000 Jul;11(6):407-17. doi: 10.1097/00001813-200007000-00001.
7
Anti-sleeping sickness drugs and cancer chemotherapy.
Parasitol Today. 2000 Jan;16(1):7-9. doi: 10.1016/s0169-4758(99)01560-4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验